NL-OMON54780
Recruiting
Not Applicable
Hemodynamic Adaptation in the Peripartum Period using Impedance cardiography (HAPPI). - HAPPI-study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Informed consent
- •\- Being in active labour (defined as progressing cervical dilatation)
- •o Or currently being induced for labour
- •o Or planned primary Caesarean section
Exclusion Criteria
- •\- Age \<18 years
- •\- Multiple pregnancy
- •\- Preterm labour \<32 weeks gestational age (GA)
- •\- Labour after intra\-uterine fetal death
- •\- Clinical cardiovascular compromise at moment of recruitment (30 weeks GA)
- •\- Abnormal placentation
- •\- Presence of the following ICG contra\-indications, as established by the
- •manufacturer to decrease measurement accuracy:
- •o Pacemaker
- •o Implantable cardioverter\-defibrillator (ICD)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Hemodynamic Adaptation to Pregnancy and Placenta-related Outcome (HAPPO study)Maternal cardiovascular adaptation and utero(placental) vascular developmentpreeclampsiasmall for gestational age10010273NL-OMON55842Erasmus MC, Universitair Medisch Centrum Rotterdam300
Recruiting
Not Applicable
Healthy heart, healthy pregnancy? How a woman's periconceptional cardiovascular health affects pregnancy outcome.PreeclampsiaPregnancy induced hypertensionFetal growth restrictionSmall for gestational ageCardiovascular disease riskPre-eclampsie (zwangerschapsvergiftiging)Zwangerschapshypertensie (hoge bloeddruk in de zwangerschap)Foetale groeivertragingTe laag geboortegewichtCardiovasculair risicoprofielNL-OMON25494Erasmus MC, University Medical Center Rotterdam300
Active, not recruiting
Not Applicable
Maternal, uteroplacental and fetal haemodynamic effect of Nicardipine in severe pre-eclampsia. - CORCA IIHypertensive crisis in patients with severe pre-eclampsia needs to be treated to prevent maternal and fetal complications. The maternal, uteroplacental and fetal haemodynamic respose to antihypertensive treatment with Nicardipinehydrochloride will be evaluated in detail by materal echocardiography and fetal doppler ultrasound as well as by the effect on plasma Brain Natriuretic Peptide concentration (BNP) and parameters of the Renin- Angiotensin- Aldosterone system (RAAS).MedDRA version: 9.1Level: LLTClassification code 10040445Term: Severe pre-eclampsia, antepartumMedDRA version: 9.1Level: LLTClassification code 10053094Term: Doppler echocardiographyMedDRA version: 9.1Level: LLTClassification code 10045412Term: Ultrasound DopplerMedDRA version: 9.1Level: LLTClassification code 10058179Term: Hypertensive emergencyMedDRA version: 9.1Level: LLTClassification code 10038555Term: ReninMedDRA version: 9.1Level: LLTClassification code 10002491Term: Angiotensin IIMedDRA version: 9.1Level: LLTClassification code 10053406Term: Brain natriuretic peptideMedDRA version: 9.1Level: LLTClassification code 10001644Term: AldosteroneEUCTR2007-000727-17-NLErasmus MC10
Suspended
Not Applicable
Cardiac Output Changes With Uterine DisplacementObstetric Anesthesia, Cardiac MonitoringNCT02283931Brigham and Women's Hospital25
Unknown
Not Applicable
Vascular Changes in Pre-Eclamptic Patients and Its Impact on Pregnancy Outcome.Pre-EclampsiaNCT03111576Beni-Suef University100